Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$276,318
-$45,900 QoQ
Shares Held
11,475
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#2,190
of 2,821 holders
Holding Since
Dec 2021
19 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WULFF, HANSEN & CO. holds $6,552,139 across 6 Drug Manufacturers - General names. PFE ranks #6 (4.2% of the industry book) .
All Filings in PFE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $276,318 | 11,475 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $322,218 | 11,475 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $285,727 | 11,475 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $292,383 | 11,475 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $297,667 | 12,280 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $256,415 | 10,119 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $247,100 | 9,314 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $295,593 | 10,214 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $268,999 | 9,614 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $266,788 | 9,614 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $276,787 | 9,614 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,033,145 | 31,147 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,142,471 | 31,147 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,298,745 | 31,832 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,631,071 | 31,832 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,394,937 | 31,877 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,671,311 | 31,877 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,650,272 | 31,877 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,861,964 | 31,532 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||